Company registration number 13509030 (England and Wales)
ALETHIO THERAPEUTICS LIMITED
(PREVIOUSLY TRADED AS ALETHIOMICS LIMITED)
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2025
PAGES FOR FILING WITH REGISTRAR
ALETHIO THERAPEUTICS LIMITED
(PREVIOUSLY TRADED AS ALETHIOMICS LIMITED)
BALANCE SHEET
AS AT
31 DECEMBER 2025
31 December 2025
- 1 -
2025
2024
£
£
£
£
Fixed assets
295,590
82,005
Current assets
2,893,957
5,758,894
Creditors: amounts falling due within one year
(5,253,164)
(748,330)
Net current (liabilities)/assets
(2,359,207)
5,010,564
Total assets less current liabilities
(2,063,617)
5,092,569
Creditors: amounts falling due after more than one year
-
0
(4,500,000)
Net (liabilities)/assets
(2,063,617)
592,569
Capital and reserves
(2,063,617)
592,569
Notes to the financial statements
1
Employees

The average number of persons, including directors, employed by the company during the year wa s as follows:

2025
2024
Number
Number
Employees
11
7
2
Off balance sheet arrangements

The company had off‑balance‑sheet rental and service charge commitments of £498,489 payable to the lessor at the year end.

Alethio Therapeutics Limited is a private company limited by shares incorporated in England and Wales. The registered office is Sovereign House, Abingdon Science Park, Barton Lane, Abingdon, England, OX14 3NB.

For the year ended 31 December 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.

These financial statements have been prepared in accordance with the micro-entity provisions and in accordance with FRS 105 'The Financial Reporting Standard applicable to the Micro-entities Regime', and have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The directors of the company have elected not to include a copy of the profit and loss account within the financial statements.true

ALETHIO THERAPEUTICS LIMITED
(PREVIOUSLY TRADED AS ALETHIOMICS LIMITED)
BALANCE SHEET (CONTINUED)
AS AT
31 DECEMBER 2025
31 December 2025
- 2 -
The financial statements were approved by the board of directors and authorised for issue on 30 March 2026 and are signed on its behalf by:
R Batta
Director
Company registration number 13509030 (England and Wales)
2025-12-31 2025-01-01 false false CCH Software CCH Accounts Production 2025.300 No description of principal activity S M Dewhurst B Psaila S Shirodkar M Throsby E Ainscow L D De Jongh R Batta M G Grey false 13509030 2025-01-01 2025-12-31 13509030 1 2025-01-01 2025-12-31 13509030 2025-12-31 13509030 2024-12-31 13509030 core:CurrentFinancialInstruments core:WithinOneYear 2025-12-31 13509030 core:CurrentFinancialInstruments core:WithinOneYear 2024-12-31 13509030 core:Non-currentFinancialInstruments 2025-12-31 13509030 core:Non-currentFinancialInstruments 2024-12-31 13509030 2024-01-01 2024-12-31 13509030 bus:Director7 2025-01-01 2025-12-31 13509030 bus:PrivateLimitedCompanyLtd 2025-01-01 2025-12-31 13509030 bus:SmallCompaniesRegimeForAccounts 2025-01-01 2025-12-31 13509030 bus:Micro-entities 2025-01-01 2025-12-31 13509030 bus:AuditExempt-NoAccountantsReport 2025-01-01 2025-12-31 13509030 bus:Director1 2025-01-01 2025-12-31 13509030 bus:Director2 2025-01-01 2025-12-31 13509030 bus:Director3 2025-01-01 2025-12-31 13509030 bus:Director4 2025-01-01 2025-12-31 13509030 bus:Director5 2025-01-01 2025-12-31 13509030 bus:Director6 2025-01-01 2025-12-31 13509030 bus:Director8 2025-01-01 2025-12-31 13509030 bus:FullAccounts 2025-01-01 2025-12-31 xbrli:pure xbrli:shares iso4217:GBP